CARISMA Therapeutics to Present at Upcoming Healthcare Industry Conferences
PHILADELPHIA, Oct. 8, 2020 /PRNewswire/ -- CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the company will present at upcoming virtual healthcare industry conferences in October 2020.
- Cell & Gene Meeting on the Mesa, October 12-16, 2020:
- The presentation given by Steven Kelly, President and CEO, will be available to view on-demand throughout the entirety of the conference.
- Macrophage-directed Therapies Summit, October 27-29, 2020:
- Michael Klichinsky, PhD, Co-Founder and Vice President of Discovery Research, will present virtually and participate in a panel discussion on October 29, 2020. Both will be accessible via webcast.
About CARISMA Therapeutics Inc.
CARISMA Therapeutics Inc. is a biopharmaceutical company developing a differentiated and proprietary cell therapy platform focused on engineered macrophages, cells that play a crucial role in both the innate and adaptive immune response. The first applications of the platform, developed in collaboration with the University of Pennsylvania, are autologous chimeric antigen receptor (CAR)-macrophages for the treatment of solid tumors. CARISMA Therapeutics is headquartered in Philadelphia, PA.
For more information, please visit www.carismatx.com
Media Contact:
Christina Khoury-Folkens
612-806-0757
ckhoury@w2ogroup.com
SOURCE CARISMA Therapeutics Inc.